Lobucavir

CAS : 127759-89-1

Ref. TR-L469360

Informations sur le produit

• Nom: Lobucavir
• Synonymes: 2-Amino-9-[(1R,2R,3S)-2,3-bis(hydroxymethyl)cyclobutyl]-1,9-dihydro-6H-purin-6-one,[1R-(1alpha,2beta,3alpha)]-2-Amino-9-[2,3-bis(hydroxymethyl)cyclobutyl]-1,9-dihydro-6H-purin-6-one, (+)-Cyclobut G, BMS 180194, SQ 34514, 2-Amino-9-[(1R,2R,3S)-2,3-bis(hydroxymethyl)cyclobutyl]-1,9-dihydro-6H-purin-6-one, 2-amino-9-[(1R,2R,3S)-2,3-bis(hydroxymethyl)cyclobutyl]-3,9-dihydro-6H-purin-6-one, 6H-Purin-6-one, 2-amino-9-((1R,2R,3S)-2,3-bis(hydroxymethyl)cyclobutyl)-1,9-dihydro-, 6H-Purin-6-one, 2-amino-9-(2,3-bis(hydroxymethyl)cyclobutyl)-1,9-dihydro, (1R-(1alpha,2beta,3alpha)), 6H-Purin-6-one, 2-amino-9-[2,3-bis(hydroxymethyl)cyclobutyl]-1,9-dihydro-, [1R-(1α,2β,3α)]-, 9-((1R,2R,3S)-2,3-Bis(hydroxymethyl)cyclobutyl)guanine, A-69992, Bms-180194, C-Oxetanocin-G, Ccris 9309, Drg-0235, Lobucavir [USAN:INN], Sq 34,514, Unii-8U5Pyq1R2E

Description

Applications A nucleoside analog used in the treatment of viral infections, including those caused by human immunodeficiency virus, cytomegalovirus, and herpes virus.
References Faulds, D., et al.: Drugs, 39, 597 (1990), Greene, J., et al.: Fundam. Appl. Toxicol., 32, 140 (1996), Poirier, M., et al.: Toxicol. Appl. Pharmacol., 199, 151 (2004),

• Marque: TRC

Propriétés chimiques

• Masse moléculaire: 265.27
• Formule: C₁₁H₁₅N₅O₃
• Couleur/Forme: Neat
• InChI: InChI=1S/C11H15N5O3/c12-11-14-9-8(10(19)15-11)13-4-16(9)7-1-5(2-17)6(7)3-18/h4-7,17-18H,1-3H2,(H3,12,14,15,19)/t5-,6-,7-/m1/s1
• Code InChI: InChIKey=GWFOVSGRNGAGDL-FSDSQADBSA-N
• SMILES: Nc1nc2c(ncn2[C@@H]2C[C@H](CO)[C@H]2CO)c(=O)[nH]1